Skip to content

Search

Refine results
Showing results 1 – 10 of 161.
Default person image
Jamal Zahra
Trials Assistant

I joined the CTU in September 2018. I work primarily on the ERIC-PPCI, safetxt and Tight K trials.

Completed Trial
Completed Trial
WOMAN Trial

Around the world, one woman dies every five minutes from excessive bleeding after giving birth, a medical complication known as postpartum haemorrhage. The majority of these women live in low- and middle-income countries where access to life-saving emergency healthcare is often limited.  The...

Current Trial
Current Trial
Locations
Trauma-INTACT

Trauma-INTACT is a prospective, open-label, multicentre, pharmacokinetic study. Objective:  To assess the population pharmacokinetics of intramuscular TXA in trauma patients. Background:  The anti-fibrinolytic TXA has been licensed for over 30 years for use in the prevention and...

Locations
Default person image
Dhaliwal, Faran
Trials Assistant

I started working at LSHTM as a Trials Assistant in April 2019 and I am currently involved in two trials: safetxt and REVIVED. Before joining the Clinical Trials Unit, I graduated from Brunel University with a BSc (Hons) in Biomedical Science and went on to work at the University of London...

Current Trial
Current Trial
WOMAN-2

Postpartum haemorrhage (PPH) is responsible for about 100,000 maternal deaths every year, almost all of which occur in low and middle income countries. When given within three hours of birth, tranexamic acid reduces deaths due to bleeding in women with PPH by almost one third. However, for many...

Publication
Publication
Lancet
Vol. 391, Issue 10122, P 736
DOI
10.1016/S0140-6736(18)30255-1
Hydroxyethyl starch solutions and patient harm.
Ian Roberts, Haleema Shakur, Rinaldo Bellomo, Julian Bion, Simon Finfer, Beverley Hunt, John Myburgh, Anders Perner Konrad Reinhart